Least developed countries vs Rwanda: Access to anti-retroviral drugs, female
Least developed countries
86.4%
in 2024
Rwanda
97.0%
in 2024
Least developed countries rank
9th
Rwanda rank
12th
Access to anti-retroviral drugs, female over time
- Least developed countries
- Rwanda
How they compare
Rwanda currently reports 97.0% against 86.4% in Least developed countries, a difference of 10.6%.
That makes Rwanda's figure about 1.1 times Least developed countries's.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
Least developed countries ranks 9th and Rwanda ranks 12th of 19 groups.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.6% | 11.1% | 5.5% | Rwanda |
| 2010s | 47.1% | 63.3% | 16.2% | Rwanda |
| 2020s | 79.6% | 90.8% | 11.2% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Least developed countries or Rwanda?
- Rwanda, at 97.0% against 86.4% in Least developed countries as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Least developed countries and Rwanda?
- 10.6%, with Rwanda ahead.
- How many years of comparable data are there for Least developed countries and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Least developed countries and Rwanda rank globally for access to anti-retroviral drugs, female?
- Least developed countries ranks 9th and Rwanda ranks 12th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.